You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal cell carcinoma (RCC)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable, Locally Advanced Or Metastatic Renal Cell

Completed
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Cabozantinib monotherapy
  • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
  • The Woodlands, Texas
    McKesson Life Sciences
Nov 11, 2021

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Salzburg, Austria
  • +39 more
Jan 18, 2023

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

Withdrawn
  • Clear-cell Renal Cell Carcinoma
  • +3 more
  • Birmingham, Alabama
    University of Alabama Hematology Oncology Clinic at Medical West
Feb 14, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

IMaging PAtients for Cancer Drug selecTion - Renal Cell

Completed
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Kidney Neoplasms
  • Molecular imaging
  • Amsterdam, Netherlands
  • +2 more
Dec 6, 2021

Renal Cell Carcinoma Trial in Leeds (Low dose abdominal computed tomography scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Low dose abdominal computed tomography scan
  • Leeds, Yorkshire, United Kingdom
    Leads Teaching Hospitals Trust
Nov 1, 2022

Carcinoma, Renal Cell Trial in France (Tivozanib, Nivolumab)

Completed
  • Carcinoma, Renal Cell
  • Bordeaux, France
  • +3 more
Dec 2, 2021

Renal Cell Carcinoma Trial in Hamilton, Toronto (SBRT)

Active, not recruiting
  • Renal Cell Carcinoma
  • SBRT
  • Hamilton, Ontario, Canada
  • +1 more
Dec 15, 2020

Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Yokohama City (89Zr-girentuximab)

Completed
  • Carcinoma, Renal Cell
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Yokohama City, Kanagawa, Japan
    Yokohama City University Hospital
Aug 18, 2021

Renal Cell Carcinoma Trial in France, Spain, United States (BMS-936558 (Anti-PD-1))

Completed
Has Results
  • Renal Cell Carcinoma
  • BMS-936558 (Anti-PD-1)
  • San Francisco, California
  • +13 more
Oct 13, 2021

Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

Recruiting
  • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Kidney Cancer Metastatic, Kidney Cancer, Kidney Cancer, Stage IV Trial in Baltimore, Dallas (Nivolumab/Ipilimumab, SBRT)

Completed
Has Results
  • Kidney Cancer Metastatic
  • +2 more
  • Baltimore, Maryland
  • +1 more
Mar 29, 2021

Utilization of Cabozantinib in Adult Advanced or Metastatic

Withdrawn
  • Renal Cell Carcinoma
    • (no location specified)
    Dec 17, 2020

    Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Los Angeles, California
    • +4 more
    Feb 14, 2022

    Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

    Recruiting
    • Aggressive Variant Prostate Carcinoma
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Renal Cell Carcinoma (RCC) Trial in Milan (18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL

    Completed
    • Renal Cell Carcinoma (RCC)
    • 18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS
    • Milan, Italy
      IRCCS San Raffaele
    Dec 18, 2020

    Renal Cell Carcinoma, Melanoma, Solid Tumor Trial in Pittsburgh (Phase Ib ARRY-614 + nivolumab, Phase Ib ARRY-614 +

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Phase Ib ARRY-614 + nivolumab
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2022

    Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

    Terminated
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • APL-501
    • +2 more
    • Albury, New South Wales, Australia
    • +8 more
    May 3, 2022

    Renal Cell Carcinoma Trial in Haifa (PROSENSE™)

    Active, not recruiting
    • Renal Cell Carcinoma
    • PROSENSE™
    • Haifa, Israel
    • +1 more
    Dec 21, 2022

    Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1 Trial in

    Recruiting
    • Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
    • Biological : Toripalimab Drug: Axitinib
    • sunitinib
    • Beijing, China
      Beijing Cancer Hospital
    Jan 24, 2021

    ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

    Active, not recruiting
    • ccRCC
    • +4 more
    • Los Angeles, California
    • +24 more
    Jul 18, 2022

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022